Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells
Abstract Nucleotide excision repair (NER) and cell cycle checkpoints impact the ability of the anti-cancer drug cisplatin to inhibit cell proliferation and induce cell death. Genetic studies have shown that both NER and cell cycle progression are impacted by the circadian clock, which has emerged as...
Guardado en:
Autores principales: | Nadeen Anabtawi, William Cvammen, Michael G. Kemp |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2b3929afad44538b799891a484445ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
por: Shangyi Wang, et al.
Publicado: (2021) -
UV Radiation in DNA Damage and Repair Involving DNA-Photolyases and Cryptochromes
por: Yuliya L. Vechtomova, et al.
Publicado: (2021) -
Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα
por: Brian J. Altman, et al.
Publicado: (2017) -
The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication
por: Xiaodong Zhuang, et al.
Publicado: (2019) -
Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models
por: Tianpeng Zhang, et al.
Publicado: (2021)